We have also observed in vivo that reducing both phospho-STAT3 and miR-21 levels in C57BL6 mice liver, by long-term treatment with metformin, a widely used anti-diabetic drug, strongly improved age dependent hepatic steatosis. This evidence concerns the gene STAT3 and fatty liver disease.